167 related articles for article (PubMed ID: 17109190)
1. The use of differential item functioning analyses to identify cultural differences in responses to the EORTC QLQ-C30.
Scott NW; Fayers PM; Aaronson NK; Bottomley A; de Graeff A; Groenvold M; Koller M; Petersen MA; Sprangers MA;
Qual Life Res; 2007 Feb; 16(1):115-29. PubMed ID: 17109190
[TBL] [Abstract][Full Text] [Related]
2. Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses.
Scott NW; Fayers PM; Bottomley A; Aaronson NK; de Graeff A; Groenvold M; Koller M; Petersen MA; Sprangers MA;
Qual Life Res; 2006 Aug; 15(6):1103-15; discussion 1117-20. PubMed ID: 16900290
[TBL] [Abstract][Full Text] [Related]
3. Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.
Scott NW; Fayers PM; Aaronson NK; Bottomley A; de Graeff A; Groenvold M; Gundy C; Koller M; Petersen MA; Sprangers MA;
Qual Life Res; 2009 Apr; 18(3):381-8. PubMed ID: 19247808
[TBL] [Abstract][Full Text] [Related]
4. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
[TBL] [Abstract][Full Text] [Related]
5. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
[TBL] [Abstract][Full Text] [Related]
6. Normative data for the EORTC QLQ-C30 from the Austrian general population.
Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
[TBL] [Abstract][Full Text] [Related]
7. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.
Liegl G; Petersen MA; Groenvold M; Aaronson NK; Costantini A; Fayers PM; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Nolte S;
Eur J Cancer; 2019 Jan; 107():133-141. PubMed ID: 30576969
[TBL] [Abstract][Full Text] [Related]
8. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
9. No impact of Asian ethnicity on EORTC QLQ-C30 scores: Group differences and differential item functioning in paroxysmal nocturnal hemoglobinuria.
Schwartz CE; Stark RB; Borowiec K; Myren KJ
Health Qual Life Outcomes; 2021 Sep; 19(1):228. PubMed ID: 34583705
[TBL] [Abstract][Full Text] [Related]
10. The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development.
Gamper EM; Groenvold M; Petersen MA; Young T; Costantini A; Aaronson N; Giesinger JM; Meraner V; Kemmler G; Holzner B;
Psychooncology; 2014 Apr; 23(4):397-403. PubMed ID: 24217943
[TBL] [Abstract][Full Text] [Related]
11. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
12. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer.
Fayers P; Bottomley A; ;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S125-33. PubMed ID: 11858978
[TBL] [Abstract][Full Text] [Related]
13. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
[TBL] [Abstract][Full Text] [Related]
14. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
[TBL] [Abstract][Full Text] [Related]
15. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30.
Lundy JJ; Coons SJ; Aaronson NK
Patient; 2015 Apr; 8(2):165-70. PubMed ID: 24958466
[TBL] [Abstract][Full Text] [Related]
16. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
[TBL] [Abstract][Full Text] [Related]
17. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
[TBL] [Abstract][Full Text] [Related]
18. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
[TBL] [Abstract][Full Text] [Related]
20. Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity.
Juul T; Petersen MA; Holzner B; Laurberg S; Christensen P; Grønvold M
Qual Life Res; 2014 Oct; 23(8):2183-93. PubMed ID: 24676897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
